tiprankstipranks
PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial
PremiumPress ReleasesPolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial
2M ago
PolyPid Ltd. (PYPD) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
PolyPid Ltd. (PYPD) Q4 Earnings Cheat Sheet
2M ago
PolyPid files to sell 6.74M ordinary shares for holders
PremiumThe Fly
PolyPid files to sell 6.74M ordinary shares for holders
3M ago
PolyPid appoints Nurit Tweezer-Zaks to board of directors
PremiumThe FlyPolyPid appoints Nurit Tweezer-Zaks to board of directors
5M ago
PolyPid to Report Third Quarter 2023 Financial Results and Operational Highlights on November 8, 2023
PremiumPress Releases
PolyPid to Report Third Quarter 2023 Financial Results and Operational Highlights on November 8, 2023
6M ago
PolyPid price target raised to $10 from $2.50 at Barclays
PremiumThe Fly
PolyPid price target raised to $10 from $2.50 at Barclays
6M ago
PolyPid announces publication of preclinical data on D-PLEX100
PremiumThe FlyPolyPid announces publication of preclinical data on D-PLEX100
7M ago
PolyPid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-PLEX₁₀₀ and PLEX Technology Platform
PremiumPress Releases
PolyPid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-PLEX₁₀₀ and PLEX Technology Platform
7M ago
PolyPid management to meet virtually with JMP Securities
PremiumThe Fly
PolyPid management to meet virtually with JMP Securities
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100